Factor Pharma News Today

A report from brokerage firm Sharekhan highlighted key factors contributing to Cipla's upward trajectory, emphasizing the company's strategic focus on complex products and the resultant impact on margins.

In a dynamic trading session on Friday, the Nifty managed to recover, reclaiming the 21,790 mark, while the Sensex recorded modest gains of approximately 150 points. However, the broader market indices, particularly the midcap and smallcap indices, faced downward pressure, each declining by 1%.

On Thursday, 1636 stocks advanced, 2,204 declined, and 105 remained unchanged on BSE with an advance decline ratio of 0.74, indicating a negative closing of stocks in broader markets.

Pharma major Cipla has generated considerable interest from private equity players. What makes it such an alluring prospect, and what does the future hold for this storied company? - Issue Date: Oct 29, 2023

With the possibility of Bain Capital and Dr Reddys entry in the race to acquire promoters stake in Cipla, competition has now intensified as firms like Torrent Pharma and Blackstone have already placed their respective bids

Stocks to watch out for today: Ramco Cements, Oil India, Mrs Bectors Food, SpiceJet, Cipla, Tata Power, YES Bank, Tata Steel and more

Cipla South Africa, a wholly-owned subsidiary of Cipla, signed a binding term sheet with Actor Holdings (Pty) to acquire Actor Pharma (Pty) Ltd.

US-based private equity firm Bain Capital is exploring a joint bid with Dr. Reddy’s Laboratories for the promoter stake

Transaction in line with our strategy of strengthening OTC and wellness portfolio, says firm

This is a strategic acquisition for Cipla South Africa to unlock future growth opportunities and leverage cost synergies in the South African market, the drug major said.